Automation can benefit pharmaceutical development by enabling the accelerated assessment of the physico-chemical characteristics of investigational new drugs utilizing high-throughput screens. Two major advantages to automation are preventing scientific staff from performing repetitive labor intensive tasks and reducing the amount of compound required for testing.

Targeted peptide quantification with small foot-print capillary LC-MS/MS
See us at AAPS PharmSci360 Nov. 9-12! Booth 3024
Axcend® announces the launch of its small footprint, full-stack chromatography system.